# LAMIVUDINE
> **ANDA078545** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2019-03-05
## Drug
- **FDA Application Number:** ANDA078545
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2019-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078545)
---
*AI Analytics · CC0 1.0*